Top Recommendations from the 2023 PCOS Evidence Guideline

Topic: Guideline digest

Scientific understanding of Polycystic Ovary Syndrome (PCOS) moves fast. What was considered “standard care” five years ago is often outdated today. That is why the release of the 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS is such a major milestone.

This massive document consolidates research from thousands of studies and expert consensus from 71 countries. While the full document is hundreds of pages long, the core recommendations are what matter for you as a patient.

Here are the top evidence-based recommendations that should be shaping your care plan right now.

1. Diagnosis: Ultrasound is Optional, AMH is In

The Recommendation: Anti-Müllerian Hormone (AMH) levels alone can now be used to diagnose PCOS in adults, replacing the need for a transvaginal ultrasound. What This Means: If you dread the pelvic ultrasound, you can advocate for a blood test instead. High AMH levels correlate strongly with polycystic ovarian morphology (PCOM). Note: This does not apply to teenagers, where ultrasound is not recommended at all.

2. Lifestyle: No “One Best Diet”

The Recommendation: There is no single “PCOS diet.” The evidence supports any sustainable way of eating that reduces insulin resistance and promotes metabolic health. What This Means: You don’t have to go Keto. You don’t have to go Vegan. You don’t have to cut gluten unless you are sensitive. The guidelines emphasize tailored nutrition—finding an approach you can stick to long-term that focuses on whole foods and glycemic control.

3. Medication: Metformin is a Key Player

The Recommendation: Metformin should be considered for women with PCOS who have a BMI ≥ 25, and heavily considered for those with metabolic risk factors (like high blood sugar), regardless of weight. What This Means: Metformin isn’t just for diabetes. It effectively lowers insulin, testosterone, and BMI in PCOS patients. It is now positioned as a stronger option alongside lifestyle changes.

4. Supplements: Inositol Gets the Stamp of Approval

The Recommendation: Inositol (specifically the 40:1 ratio of Myo-Inositol to D-Chiro-Inositol) is recognized as an effective treatment for metabolic and ovulatory symptoms. What This Means: This is a huge win for integrative medicine. The guidelines acknowledge that Inositol can offer similar benefits to Metformin with fewer gastrointestinal side effects, making it a valid option for many women.

5. Fertility: Letrozole First

The Recommendation: Letrozole is the first-line pharmacological treatment for ovulation induction in women with PCOS who are trying to conceive. What This Means: If your doctor starts with Clomid (Clomiphene), ask why. The evidence shows Letrozole leads to higher live birth rates and fewer multiple pregnancies for PCOS patients specifically.

6. Psychology: Screen for Anxiety & Depression

The Recommendation: All health professionals should screen women with PCOS for anxiety and depressive symptoms at diagnosis. What This Means: It confirms the biological link between hormonal health and mental health. If you are struggling emotionally, it is not a “side issue”—it is a core part of your PCOS that deserves treatment.

7. Cardiovascular Health: Check the Heart

The Recommendation: All women with PCOS should have their cardiovascular risk assessed (blood pressure, lipid profile) regardless of age or BMI. What This Means: PCOS is a lifelong metabolic condition. Protecting your heart starts in your 20s and 30s. Regular checks ensure you don’t face preventable heart issues later in life.

How to Use This Information

These guidelines are public knowledge, but not every provider stays up to date. If your care plan contradicts these points (e.g., being told “just lose weight” without metabolic support, or being forced to have an ultrasound), print the summary of the 2023 Guidelines and bring it to your appointment.

Evidence-based care isn’t a luxury; it is the standard you deserve.